Case Control Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Oct 14, 2016; 22(38): 8540-8548
Published online Oct 14, 2016. doi: 10.3748/wjg.v22.i38.8540
Table 1 Basal characteristic in patients with bipolar disorder and control subjects representative of a general population
Bipolar disorderControlsP value
(n = 136)(n = 136)
Mean age (SD) (yr)49.9 (14.1)51.0 (11.4)0.505
Women61% (n = 83)60% (n = 81)0.804
Mean body mass index (SD) (kg/m2)27.0 (5.50)25.41 (3.19)0.0051
Median HADS scores (IQR):
HADS-anxiety5 (7)4 (5)0.0011
HADS-depression3 (5)3 (3)0.0221
PSQ index (IQR)0.27 (0.27)NA
Median GSRS scores (IQR):
Abdominal pain1.00 (2.00)0.50 (1.50)0.076
Bloating1.00 (1.67)0.50 (1.34)0.419
Diarrhoea0.50 (1.50)0.25 (0.75)0.0021
Constipation0 (2.00)0 (1.00)0.310
Satiety0 (1.00)0 (0.50)0.0191
Dyspepsia0 (1.00)0.33 (0.67)0.850
Reflux0 (1.00)0 (0.50)0.376
Total GSRS-IBS9.00 (17.00)7.00 (13.00)0.0201
Consulters for:
Any functional GI disorder25% (n = 34)17% (n = 23)0.108
IBS12% (n = 17)10% (n = 14)0.582
Table 2 Control subjects and patients with bipolar disorder with low scores on depression and low scores on anxiety score vs patients with high scores on depression and/or high scores on anxiety
Bipolar patients with HADS-D ≥ 8 and/or HADS-A ≥ 9 (n = 48)Bipolar patients with HADS-D < 8 and HADS-A < 9 (n = 88)Controls with HADS-D < 8 and HADS-A < 9 (n = 118)
Mean age (SD) (yr)46.7 (12.8) (P = 0.048)151.7 (14.4)51.5 (11.8) (P = 0.903)
Proportions of women58% (n = 28) (P = 0.634)62% (n = 55)59% (n = 70) (P = 0.644)
Mean Body mass index (kg/m2) (SD)27.2 (4.6) (P = 0.632)26.8 (5.97)25.6 (3.26) (P = 0.063)
Median HADS score (IQR)
HADS-anxiety10.5 (5.0)3.0 (4.0)3.0 (4.0) (P = 0.660)
HADS-depression9.0 (9.0)2.0 (3.0)2.0 (3.0) (P = 0.505)
PSQ index (IQR)0.47 (0.28) (P < 0.001)10.20 (0.17)NA
Median GSRS score (IQR):
Abdominal pain1.50 (2.50) (P = 0.002)10.50 (1.50)0 (1.50) (P = 0.558)
Bloating1.67 (2.33) (P < 0.001)10.67 (1.33)0.67 (1.67) (P = 0.415)
Diarrhoea1.25 (2.25) (P < 0.001)10.50 (1.00)0.25 (0.75) (P = 0.107)
Constipation0 (2.00) (P = 0.380)0 (1.50)0 (1.00) (P = 0.453)
Satiety0.50 (2.00) (P = 0.003)10 (0.50)0 (0.50) (P = 0.513)
Dyspepsia0.67 (1.33) (P = 0.002)10 (0.67)0.33 (0.67) (P = 0.291)
Reflux0 (2.13) (P = 0.098)0 (0.88)0 (0.50) (P = 0.796)
Total GSRS-IBS15.0 (23.0) (P < 0.001)17.00 (12.0)6.50 (13.0) (P = 0.513)
Consulters:
For any functional GI disorder29% (n = 14) (P = 0.407)23% (n = 20)14% (n = 17) (P = 0.131)
IBS17% (n = 8) (P = 0.290)10% (n = 9)10% (n = 12) (P = 0.995)
Median number of drugs (IQR)3.0 (3.0) (P = 0.557)3.0 (3.0)1.0 (2.0) (P < 0.001)1
Table 3 Hospital Anxiety Depression Scale scores and Perceived Stress Questionnaire index in correlation to different gastrointestinal symptom scores in patients with bipolar disorder (n = 136)
HADS-Anxiety score.HADS-Depression score.PSQ index.
rs (P value)rs (P value)rs (P value)
Abdominal pain0.295 (0.001)10.248 (0.004)10.261 (0.002)1
Bloating0.304 (< 0.001)10.365 (< 0.001)10.376 (< 0.001)1
Diarrhoea0.334 (< 0.001)10.225 (0.009)10.268 (0.002)1
Constipation0.099 (0.254)0.028 (0.751)0.063 (0.473)
Satiety0.222 (0.010)10.253 (0.003)10.333 (< 0.001)1
Dyspepsia0.293 (0.001)10.205 (0.017)10.287 (0.001)1
Reflux0.245 (0.004)10.122 (0.160)0.235 (0.007)1
Total GSRS-IBS score0.336 (< 0.001)10.328 (< 0.001)10.348 (< 0.001)1
Table 4 Comparison between patients with bipolar disorder who report high respective low scores on the Gastrointestinal Symptom Rating Scale for Irritable Bowel Syndrome
HIGH GSRS-IBS SCORELOW GSRS-IBS SCOREP value
(> 9)( ≤ 9)
(n = 65)(n = 71)
Mean age (SD)(yr)49.7 (13.7)50.1 (14.5)0.571
Women71% (n = 46)52% (n = 37)0.0261
BMI (SD)27.2 (4.46)26.7 (6.32)0.45
Median HADS scores (IQR)
Anxiety score (median)6.0 (9.0)4.0 (6.0)0.0011
Depression score (median)4.0 (8.0)2.0 (4.0)0.0021
PSQ index (IQR)0.32 (0.26)0.21 (0.23)< 0.0011
Consulters for:
Any functional GI disorder29% (n = 19)21% (n = 15)0.276
IBS18% (n = 12)7% (n = 5)0.067
Bipolar type I46% (n = 40)54% (n = 48)0.460
Bipolar type II52% (n = 25)37% (n = 23)
Medications:
Lithium51% (n = 33)42% (n = 31)0.320
Neuroleptics28% (n = 18)20% (n = 14)0.273
Anti-epileptics31% (n = 20)34% (n = 24)0.706
SSRI14% (n = 9)11% (n = 8)0.796
SNRI9% (n = 6)6% (n = 4)0.519
Benzodiazepines17% (n = 11)6% (n = 4)0.053
Drugs for insomnia26% (n = 17)10% (n = 7)0.0141
Drugs for IBS11% (n = 7)1% (n = 1)0.0281
Antacids15% (n = 10)7% (n = 5)0.171
Statines12% (n = 8)8% (n = 6)0.575
Levothyroxine26% (n = 17)13% (n = 9)0.052
≥ 3 drugs64% (n = 41)54% (n = 38)0.214
Table 5 Logistic regression analysis studying factors which may influence gastrointestinal symptoms in patients with bipolar disorder
Patients with bipolar disorder and GSRS-IBS > 9 vs patients with bipolar disorder and GSRS-IBS ≤ 9
Unadjusted ORAdjusted OR
Age1.00 (0.97-1.03)1.01 (0.97-1.04)
Sex2.23 (1.09-4.52)12.37 (1.07-5.24)1
(male reference)
Body mass index1.02 (0.95-1.09)1.01 (0.93-1.08)
HADS-Depression ≥ 85.54 (2.07-14.8)13.64 (1.07-12.4)1
(< 8 reference)
HADS-Anxiety ≥ 92.89 (1.34-6.22)11.82 (0.64-5.22)
(< 9 reference)
PSQ index ( ≤ 0.34 reference)2.53 (1.21-5.30)11.30 (0.42-3.99)
Number of Drugs ≥ 31.55 (0.77-3.09)1.29 (0.59-2.80)
(< 3 reference)